Get the latest tech news
Big Pharma’s fight against drug price reforms takes weird, desperate turn
PhRMA claims price negotiations raise costs and that drug patents lower them.
Enlarge/ Stephen Ubl, president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), speaks during a Bloomberg Live discussion in Washington, DC, in 2017. In a statement that provided links to PhRMA's efforts this week, White House spokesperson Andrew Bates called Big Pharma's pricing on drugs "corporate rip-offs." "Now that President Biden is delivering real savings for the families who have been overcharged by Big Pharma for medicines they desperately need, they're continuing to fight tooth and nail against the financial interests of American seniors," Bates said.
Or read this on r/technology
